Breast cancer risk in relation to plasma metabolites among Hispanic and African American women

[1] Siegel RL(2018)Cancer statistics, 2018 CA Cancer J Clin 68 7-30

[2] Miller KD(2017)Assessing the racial and ethnic disparities in breast cancer mortality in the United States Int J Environ Res Public Health 84 1-7

[3] Jemal A(2012)Metabolomics in cancer: a bench-to-bedside intersection Crit Rev Oncol Hematol 106 637-649

[4] Yedjou CG(2014)Genetic determinants influencing human serum metabolome among African Americans PLoS Genet 110 588-597

[5] Tchounwou PB(2017)Nutritional metabolomics and breast cancer risk in a prospective study Am J Clin Nutr 6 757-765

[6] Payton M(2018)A metabolomics analysis of body mass index and postmenopausal breast cancer risk J Natl Cancer Inst 23 1422-1431

[7] Miele L(2013)Plasma metabolomic profiles in breast cancer patients and healthy controls: by race and tumor receptor subtypes Transl Oncol 9 128-139

[8] Fonseca DD(2017)Serum metabolomic profiles identify ER-positive early breast cancer patients at increased risk of disease recurrence in a multicenter population Clin Cancer Res 22 1295-1301

[9] Lowe L(2015)Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study Mol Oncol 424 3-7

[10] Alo RA(2011)Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods Ann Oncol 9 12868-12878

[1] Siegel RL(2018)Cancer statistics, 2018 CA Cancer J Clin 68 7-30

[2] Miller KD(2017)Assessing the racial and ethnic disparities in breast cancer mortality in the United States Int J Environ Res Public Health 84 1-7

[3] Jemal A(2012)Metabolomics in cancer: a bench-to-bedside intersection Crit Rev Oncol Hematol 106 637-649

[4] Yedjou CG(2014)Genetic determinants influencing human serum metabolome among African Americans PLoS Genet 110 588-597

[5] Tchounwou PB(2017)Nutritional metabolomics and breast cancer risk in a prospective study Am J Clin Nutr 6 757-765

[6] Payton M(2018)A metabolomics analysis of body mass index and postmenopausal breast cancer risk J Natl Cancer Inst 23 1422-1431

[7] Miele L(2013)Plasma metabolomic profiles in breast cancer patients and healthy controls: by race and tumor receptor subtypes Transl Oncol 9 128-139

[8] Fonseca DD(2017)Serum metabolomic profiles identify ER-positive early breast cancer patients at increased risk of disease recurrence in a multicenter population Clin Cancer Res 22 1295-1301

[9] Lowe L(2015)Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study Mol Oncol 424 3-7

[10] Alo RA(2011)Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods Ann Oncol 9 12868-12878